What You Should Know: - Today, Sema4, a leader in AI-driven clinical data intelligence, announced that they have partnered with BioSymetrics, to accelerate the advancement of drug discovery and new treatments for patients and pharmaceutical companies. - Together the two will leverage Sema4’s Centrellis®, one of the largest and fastest-growing integrated health information platforms that includes approximately 12 million de-identified clinical records, and Elion, BioSymetrics’
Read More
BioSymetrics
BioSymetrics Launches New AI Capability to Improve Patient Outcomes
- First biomedical machine learning framework BioSymetrics introduces a new component that enables users to reduce bias, increase speed to market and improve patient outcomes.
- Augusta Architect enables data scientists in hospitals, healthcare systems, and pharmaceutical companies to perform fast, effective data pre-processing and ML. - New component has a simple syntax that allows users to quickly process and integrate multiple, diverse datatypes and run or compare multiple ML
Read More
BioSymetrics Launches Analytics Platform to Revolutionize AI in Biomedicine
BioSymetrics, Inc., a technology company that aims to transform data analytics for the biomedical industry, today announced the launch of its pre-processing and analytics platform, Augusta. Augusta is a proprietary technology that allows standardized processing and integration of multiple, diverse raw data types, facilitating rapid deployment of AI projects in precision medicine, drug discovery, and digital health data applications. Currently, Augusta provides over 150 modules for the processing
Read More
